Application of enteral nutrient in preparation of preparation for improving prognosis of encephaledema, pulmonary edema and pleural effusion of patient with craniocerebral injury
By adjusting the thermal nitrogen ratio and nutrient ratio of enteral nutrients, the problems of hyperglycemia caused by excessive thermal nitrogen ratio in the prior art are solved, and the albumin level of patients with craniocerebral injury is significantly improved. Shortened ICU stay time and medical expenses and improved prognosis.
Patent Information
- Application Number
- CN202410826828.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-06-25
- Publication Date
- 2024-11-26
AI Technical Summary
The range of hot-nitrogen ratios of existing enteral nutritional agents is too wide, resulting in problems such as stress hyperglycemia, hypoproteinemia, cerebral edema and pulmonary edema in patients with craniocerebral injury, making it difficult to effectively improve prognosis and shorten the hospital stay.
By adjusting the non-protein hot-nitrogen ratio range of enteral nutrients to 85-95:1, increase protein intake, reduce carbohydrate and fat intake, ensure that the total daily energy intake remains unchanged, and reduce the hot-nitrogen ratio to increase whitening Protein levels, alleviate hyperglycemia thresholds, shorten ICU stay and medical expenses.
It significantly increased the albumin level of patients with severe craniocerebral injury, lowered the threshold for hyperglycemia, shortened the ICU stay and ventilator use time, reduced the formation of pleural effusion, reduced medical expenses, and improved patient prognosis.
Smart Images

Figure FT_1 
Figure BDA0004910746500000051 
Figure BDA0004910746500000061
Abstract
Description
Technical Field
[0001] The invention relates to the field of nutrient agents, in particular to the use of an enteral nutrient agent in the preparation of a preparation for improving brain edema, pulmonary edema, pleural effusion and prognosis in patients with craniocerebral injury. Background Art
[0002] Energy nitrogen ratio is a term for parenteral and enteral nutrition published by the National Committee for the Examination of Scientific and Technological Terms in 2019. It comes from the first edition of the "Terms of Parenteral and Enteral Nutrition". It is defined as the ratio of non-protein calories (kcal) to nitrogen (g) in nutritional preparations.
[0003] The empirical heat-nitrogen ratio range in enteral nutrition preparations is 100-150:1. The Chinese Expert Consensus on Enteral Nutrition Support for Neurological Diseases (Second Edition) clearly states: The recommended range of heat-nitrogen ratio for patients with neurological diseases is 100-150:1 (this recommendation is a Grade A recommendation).
[0004] The Chinese Journal of Clinical Nutrition (Volume 27, Issue 4, August 2019, 197) points out that for critically ill patients in the acute phase, the heat-nitrogen ratio = 100:1.
[0005] Clinical nutrition clearly states that sugar accounts for 65% to 75% of total calories, fat accounts for 15% to 20% of total calories, and protein accounts for 10% to 15% of total calories. Therefore, clinical nutrition recommends that the non-protein calories: nitrogen content (heat-nitrogen ratio) should be 108-187.5:1.
[0006] In summary, all relevant enteral nutrition guidelines and consensus recommend that the non-protein heat-nitrogen ratio in enteral nutrition be 100-150:1.
[0007] The existing guidelines all recommend that the protein requirement is generally 0.8-1.2g / (Kg·d). The Clinical Pharmacy Practice Consensus of Enteral and Parenteral Nutrition (2022 Edition) and Today's Pharmacy (June 2023, Vol. 33, No. 6, P417) point out that the protein requirement is generally 0.8-1.2g·kg -1 ·d -1 . Summary of the invention
[0008] The technical problem to be solved by the present invention is to provide an enteral nutrient agent for use in the preparation of a preparation for improving brain edema, pulmonary edema, pleural effusion and prognosis of patients with craniocerebral injury, in view of the deficiencies in the existing technology, which helps to reduce the hospitalization time and hospitalization costs of patients with craniocerebral injury and improve the prognosis.
[0009] In order to solve the above technical problems, the technical solution adopted by the present invention is: use of an enteral nutrient in the preparation of a preparation for improving the prognosis of craniocerebral injury, wherein the non-protein heat-nitrogen ratio of the enteral nutrient is in the range of 85-95:1.
[0010] Preferably, the non-protein heat to nitrogen ratio of the enteral nutrient is in the range of 90-95:1.
[0011] The enteral nutrition preparation of the present application significantly reduces the heat-nitrogen ratio range, can significantly reduce the hyperglycemia threshold, alleviate cerebral edema, increase the albumin content in the blood, reduce the time of ICU stay, and reduce medical expenses.
[0012] In a preferred embodiment of the present invention, the enteral nutrition agent is used for nutritional support of patients with severe craniocerebral injury, satisfying the patient's daily total energy (including protein) intake of 2100-2300 Kcal (35-38 Kcal / kg calculated based on 60 kg), daily protein intake of 120-125 g / d, and non-protein calories of 1600-1800 kcal (26.6-30 Kcal / kg, calculated based on 60 kg).
[0013] Non-protein calories are 1600-1800 kcal, and the patient's daily nitrogen intake is the mass of protein / 6.25. The heat-nitrogen ratio = non-protein calories (kcal) / nitrogen (g).
[0014] The patient's daily protein intake should be 1.8-2.2g / (kg*d) and the non-protein daily calorie intake should be 26.6-30kcal / (kg*d).
[0015] The enteral nutrition preparation of the present application reduces the heat-nitrogen ratio range of the enteral nutrition preparation to 85-95:1 while maintaining 500ml:750Kcal unchanged.
[0016] In a preferred embodiment of the present invention, the total daily calorie intake is ensured to be in the range of 2100-2300 Kcal, the patient's daily carbohydrate intake is 200-250 g, protein is 115-125 g, fat is 70-78 g, and the rest is vitamins and minerals.
[0017] In a preferred embodiment of the present invention, the carbohydrates include 7-7.5 parts of monosaccharides, 75-80 parts of polysaccharides and lactose, and the lactose content is <0.185 parts, calculated by mass.
[0018] In a preferred embodiment of the present invention, the fat comprises 2-2.5 parts of saturated fatty acids and 8-8.5 parts of polyunsaturated fatty acids, calculated by mass.
[0019] In a preferred embodiment of the present invention, the minerals include 0.5-0.7 parts of Na, 0.9-1 parts of K, 0.8-0.9 parts of CL, 0.4-0.5 parts of Ca, 0.4-0.5 parts of P, and 0.1-0.2 parts of Mg, calculated by mass.
[0020] In a preferred embodiment of the present invention, an enteral nutrition agent with an energy of 740-750Kcal includes Na 0.5-0.7g, K 0.9-1g, CL 0.8-0.9g, Ca 0.4-0.5g, P 0.4-0.5g, Mg 0.1-0.2g, Fe 10-20mg, Zn 5-10mg, Cu 1100-1200ug, Mn 2000-2200ug, F 740-760ug, Mo 60-80ug, Se 30-50ug, Cr 40-50ug, and I 80-100ug.
[0021] In a preferred embodiment of the present invention, an enteral nutrition agent with an energy of 740-750Kcal includes 1900-2100IU of vitamin A, 1.3-1.7mg of carotenoid mixture, 9-11ug of vitamin D, 120-130ug of vitamin D3, 10-20mg of vitamin E, 30-40ug of vitamin K, 1-2mg of vitamin B1, 1-2mg of vitamin B2, 7-9mg of niacin, 4-6mg of pantothenic acid, 1-2mg of vitamin B6, 210-230ug of folic acid, 2-3ug of vitamin B12, 70-90ug of biotin, 70-90mg of Vc, and 220-260mg of choline.
[0022] Preferably, the craniocerebral injury is severe craniocerebral injury.
[0023] The present invention also discloses an enteral nutrient for use in preparing a preparation for improving brain edema, pulmonary edema, pleural effusion and prognosis after craniocerebral injury, wherein the heat-nitrogen ratio of the enteral nutrient is in the range of 85-95:1.
[0024] Compared with the prior art, the present invention has the following beneficial effects:
[0025] The heat-nitrogen ratio of existing enteral nutrition preparations on the market is between 100-150:1. The use of existing enteral nutrition preparations will often lead to stress hyperglycemia, hypoproteinemia and other characteristics. If the nutrition is not well managed, it will lead to the risk of cerebral edema, persistent hyperglycemia and even pulmonary edema and large amounts of pleural effusion in patients with craniocerebral injury, making it difficult to be weaned from the ventilator.
[0026] The enteral nutrition preparation of the present application, under the premise of maintaining 500ml:750Kcal unchanged, increases the protein content to 40g, reduces the total carbohydrate content to 89g, reduces the fat content to 26g, and reduces the non-protein heat-nitrogen ratio to 91:1, thereby increasing protein intake, significantly improving the albumin level of such patients, lowering the hyperglycemia threshold, reducing ICU stay and hospital stay time, and reducing medical expenses. BRIEF DESCRIPTION OF THE DRAWINGS
[0027] Figure 1 These are parameters of some commercial enteral nutrition agents. DETAILED DESCRIPTION
[0028] 1.1 General Information
[0029] A total of 60 patients with severe craniocerebral injury in the Department of Critical Care Medicine of Hunan Second People's Hospital from December 1, 2021 to November 30, 2023 were selected as the research subjects. This experiment has been reviewed by the Ethics Committee of this hospital (Ethics Review Number 2020K026). The 60 patients who met the inclusion criteria were numbered in sequence and divided into a control group (30 cases) and a study group (30 cases) by a random number table using a completely randomized method. There was no statistically significant difference in the baseline data of the two groups of patients, P < 0.05, and they can be compared.
[0030] 1.2 Inclusion and Exclusion Criteria:
[0031] (1) Blind method: This study followed the single-blind principle. The subjects were unaware of their grouping. The researchers were aware of the subjects' grouping and completed their respective nutritional support plans according to their grouping during the intervention period. The nursing staff were unaware of the subjects' grouping.
[0032] (2) Inclusion criteria: patients diagnosed with severe craniocerebral trauma (surgical or non-surgical); GCS score 3-8 points; mNUTRIC score ≤ 6 points; patients or their family members gave informed consent for this study.
[0033] (3) Exclusion criteria: patients with an mNUTRIC score greater than 6 points were excluded; patients with a history of chronic renal insufficiency (failure) or acute renal insufficiency (failure) after admission; patients with severe gastrointestinal bleeding; patients with other contraindications to enteral nutrition, such as those undergoing prone ventilation, were excluded.
[0034] (4) Exit criteria: The subjects or their family members may request to terminate the study at any time. The researchers may request the subjects to withdraw from the study at any time during the intervention period for safety reasons or because the subjects cannot tolerate or follow the study procedures. During the intervention period, if the research physician determines that any serious adverse events have occurred and that the study-related treatment needs to be stopped or changed, the subject will withdraw from the study and the reasons will be recorded in detail. Follow-up failure means that the subject dies or gives up discharge or transfer to another hospital for treatment.
[0035] (5) Exclusion criteria: failure to obtain informed consent; incomplete experimental data records; progression of the disease and need for emergency rescue of the patient or other unforeseen events;
[0036] (6) Definition of adverse events: patients with severe gastric retention and severe reflux aspiration; stress ulcers and gastrointestinal bleeding; persistent abdominal distension that persists after medication and other treatments; constipation and no bowel movements for more than 4 days; persistent diarrhea that does not improve after medication treatment.
[0037] 1.3 Methods
[0038] Under the premise of ensuring that the total calorie intake remains unchanged, the heat-nitrogen ratio is reduced, and then biochemical indicators such as serum albumin at different times, average ICU stay and other data are observed to explore the feasibility of this plan, and the distribution of protein, carbohydrates, and fat is compared with various existing enteral nutrition preparations, so as to provide a new treatment plan for enteral nutrition support for patients with severe brain injury.
[0039] (1) The patients in the control group followed the Chinese expert consensus on enteral nutrition management for patients with craniocerebral trauma (2019) and, after excluding relevant contraindications to enteral nutrition, routinely placed a nasojejunal tube (gastrointestinal nutrition tube produced by Enosun Medical Co., Ltd., 12fr) after admission or surgery to prevent reflux aspiration. 140cm), enteral nutrition support treatment within 24-48 hours, 500ml of 5% glucose and sodium chloride injection was pumped into the jejunal tube at 50ml / h on the first day to observe the gastrointestinal tolerance; if there was no obvious gastrointestinal bleeding or other enteral nutrition contraindications, enteral nutrition was started on the next day, using enteral nutrition suspension (TPF) produced by Nutricia Pharmaceuticals (Wuxi) Co., Ltd., trade name: Nengquanli (500ml, 750Kcal), injected through the nasojejunal tube at 20ml-25ml / h, increased by 10-20ml every 4-8h, and gradually increased to 1500ml (3 bottles, total calories 2250Kca, of which non-protein calories were 1898Kcal), to meet the patient's daily non-protein energy intake of about 30Kcal / Kg, and protein intake of 90g / d. The protein intake is about 1.5g / (kg*d) (calculated based on 60Kg), and the heat-nitrogen ratio is about 131:1.
[0040] (2) The nutrition of the study group on the first day was the same as that of the control group. After excluding relevant enteral nutrition contraindications, in order to prevent reflux aspiration, a nasojejunal tube (gastrointestinal nutrition tube produced by Enosun Medical Co., Ltd., 12fr 140cm) was routinely placed after admission or surgery, and enteral nutrition support treatment was performed within 24-48 hours. On the first day, 500ml of 5% glucose and sodium chloride injection was pumped into the jejunal tube at 50ml / h to observe gastrointestinal tolerance; if there were no obvious gastrointestinal bleeding and other contraindications, enteral nutrition was started the next day, using the enteral nutrition agent of this embodiment (500ml, 750Kcal), injected through the nasojejunal tube at 20ml-25ml / h, and increased by 10-20ml every 4-8h (same as the control group). According to the patient's gastrointestinal nutrition tolerance, you can choose to supplement 3 bottles of enteral nutrition agent of this embodiment daily from the third or fourth day to within one week. The specific nutritional components are as described in Table 1:
[0041] Table 1 Nutrient composition of enteral nutrition in the study group
[0042]
[0043]
[0044] The research group ensured that the total daily calorie intake remained unchanged (2250Kcal), meeting the patients' daily non-protein energy intake of 25-30Kcal / Kg. The protein intake increased to 120g / d, and the protein intake rose to 2.0g / (kg*d) (calculated based on 60Kg). The non-protein calorie intake dropped to 1770kcal, so the heat-nitrogen ratio dropped to about 1770 / (120 / 6.25)=92.18.
[0045] Table 2 Three major nutrients and heat-nitrogen ratio in energy-saving
[0046]
[0047] Table 3 Comparison of calories and heat-nitrogen ratio between the study group and the control group
[0048]
[0049] 1.4 Observation indicators
[0050] To evaluate the effectiveness and safety of this energy distribution ratio in patients with severe craniocerebral trauma and to explore a new energy distribution ratio for such patients.
[0051] 1.4.1 Main outcome measures
[0052] Record the patient's dynamic review before and 1-2 days after the start of enteral nutrition. Under the premise of ensuring that the patient's daily total calories remain unchanged, record the levels of prealbumin (PAB), serum total protein (TP), albumin (ALB), transferrin (TRF), and hemoglobin (Hb) of all patients.
[0053] 1.4.2 Secondary Observation Index
[0054] The blood sugar changes after admission, average blood sugar level, ICU stay time, presence or absence of pleural effusion, intravenous human albumin use, number of days of ventilator treatment, and number of days of ICU stay were recorded.
[0055] 1.4.3 Commonly used scoring systems
[0056] APACHEII score, SOFA score, and NutriScore score.
[0057] 1.5 Statistical analysis
[0058] For the collected data, the quantitative data were expressed as mean ± standard deviation. The experimental data were statistically analyzed using two-sample t-test and repeated measurement data F-test, intra-group comparison was performed using LSD-t test, and counting data were analyzed using chi-square test. SPSS20.0 software was used for operation, and the significance level was set at = 0.05, (P<0.05) was statistically significant.
[0059] 2 Results
[0060] 2.1 Comparison of blood biochemical indicators between the two groups of patients
[0061] Before treatment, there were no statistically significant differences in blood biochemical indices such as prealbumin (PAB), serum total protein (TP), albumin (ALB), transferrin (TRF), hemoglobin (Hb), and blood glucose (GLU) 2 hours after enteral nutrition between the two groups of patients with severe craniocerebral injury (P>0.05). After treatment, the blood biochemical indices of the two groups of patients were improved compared with those before treatment (P<0.05). The serum prealbumin and other indices in the observation group were significantly higher than those in the control group, and the blood glucose index was lower than that in the control group (P<0.05), as shown in Table 4.
[0062] Table 4 Comparison of blood biochemical indicators between the two patients ( n1=n2=30)
[0063]
[0064]
[0065] 2.2 Comparison of NutriScore between the two groups
[0066] Through the generalized NutriScore score, renal function indicators such as creatinine and urea nitrogen were included in the SOFA score in the NutriScore score. The age factor had no statistical significance between the two groups before treatment. For convenience, it was still included in the APACHEII score for comparison. The generalized NutriScore score was calculated separately, and it was found that there was no statistical difference in the generalized NutriScore scores of the two groups of patients before treatment. After treatment, the generalized NutriScore score of the observation group was lower than that of the control group, P < 0.05. The results are shown in Table 5.
[0067] Table 5 Comparison of NutriScore scores between the two groups of patients
[0068]
[0069] 2.3 The two groups of patients were compared in terms of ICU stay time, presence of pleural effusion, intravenous human albumin, and number of days of ventilator treatment. The observation group was better than the control group (P < 0.05). See Table 6.
[0070] Table 6 Comparison of other variables between the two groups of patients n(%)]
[0071]
[0072] 3 Discussions
[0073] Postoperative nutritional support for patients with craniocerebral injury is a global problem. The mortality rate of patients with severe craniocerebral trauma is >20%, and the severe disability rate is >50%. Patients undergo various physiological changes after surgery: long-term high energy demand varies greatly; patients with severe craniocerebral injury often experience persistent hypoproteinemia and stress hyperglycemia after enteral nutrition, which aggravates cerebral edema, pulmonary edema, causes pleural effusion, aggravates the condition, and makes it difficult for patients to be weaned from the ventilator. In order to improve the prognosis, it is necessary to adjust the proportion of various nutrients supported by postoperative patients under the guarantee of sufficient calories and reduce the heat-nitrogen ratio. Looking at the various enteral nutrition preparations currently on the market, the empirical heat-nitrogen ratio range in enteral nutrition preparations is 100-150:1.
[0074] Under the premise of maintaining the total calories unchanged, this study reduced the heat-nitrogen ratio of patients with severe craniocerebral injury, increased protein intake, and reduced carbohydrate and fat intake. The methods have significantly improved the patients' prealbumin, plasma albumin, and transferrin, reduced the level of stress hyperglycemia, shortened the ICU stay, shortened the time of using ventilators, reduced the use of venous human albumin, and reduced the formation of pleural effusion. By adjusting the ratio of the three major energy substances in enteral nutrition preparations, the protein content can be increased while meeting the body's calorie requirements, various complications caused by hypoproteinemia can be prevented, the prognosis of patients can be improved, and medical costs can be reduced.
[0075] In the past 25 years, enteral nutrition formulas for hospitalized patients have increased significantly, including formulas for diabetics (oligosaccharides, fructose, corn syrup, cellulose), formulas for liver disease patients (containing branched-chain amino acids), and formulas for lung disease patients (COPD patients have a high fat content, and ARDS patients have a moderately high fat content), but there are currently no enteral nutrition preparations specifically for patients with severe craniocerebral injury on the market. The primary ingredient of enteral nutrition formulas is carbohydrates, which account for 30%-70% of all calories. The optimal supply level of carbohydrates should maximize protein storage while minimizing the risk of hyperglycemia. The safe dose of carbohydrates that can be provided to critically ill patients should be consistent with their ability to oxidize carbohydrates. Each gram of glucose can produce 4kcal of energy after oxidation. It is recommended that daily carbohydrate intake should not exceed 100-150g at the beginning, and the infusion rate should not exceed 4-5mg / min*kg. The protein requirements of critically ill patients have not yet been clearly understood. Excessive fat can lead to hypertriglyceridemia and excessive fat load, with manifestations including respiratory distress, coagulopathy, abnormal liver function, and impaired reticuloendothelial system function.
[0076] The goal of nutritional support for patients with severe craniocerebral injury is to support patients through the peak of edema and reduce complications. Therefore, it is safe and feasible in clinical work to redistribute various energy substances in enteral nutrition and reduce the heat-nitrogen ratio under the premise of unchanged total daily calorie intake. This program is also conducive to reducing brain edema, reducing the occurrence of pulmonary edema, and reducing the formation of pleural effusion; reducing carbohydrate intake is conducive to blood sugar control; thereby improving clinical outcomes, shortening the patient's stay in the ICU, reducing medical costs, and bringing good social and economic benefits.
[0077] Results: The serum total protein, prealbumin, albumin and hemoglobin in the observation group were significantly higher than those before treatment and higher than those in the control group, P < 0.05. The other variables of the two groups of patients, such as: ICU stay (days), presence or absence of pleural effusion, intravenous human albumin, and ventilator treatment (days), were better in the observation group than in the control group, P < 0.05.
[0078] Based on the above results, this study controlled the heat-nitrogen ratio at 91:1 for the first time, which is lower than the conventional 100-150:1, to observe the nutritional status of patients with severe craniocerebral injury, especially the effect on albumin and prealbumin levels, and to observe the levels of prealbumin and serum albumin after increasing protein intake, providing new treatment ideas and directions for enteral nutrition support treatment for patients with severe craniocerebral injury. The results showed that the new scheme increased the protein content and reduced the carbohydrate and fat content in enteral nutrition: significantly increased the levels of prealbumin, plasma albumin, and transferrin, reduced the threshold of hyperglycemia, reduced the use of venous human albumin, reduced the formation of pleural effusion, shortened the time of ventilator application, shortened the time of ICU stay, prevented various complications caused by hypoproteinemia, improved patient prognosis, and reduced medical expenses. Since this study did not design the mortality rate and the sample size was small, the study on the prognosis of patients with severe craniocerebral injury with different heat-nitrogen ratios with equal calories still needs to be confirmed by large-scale, multicenter and better designed RCT studies.
Claims
1. Use of an enteral nutrition agent in the preparation of a preparation for improving the prognosis of patients with craniocerebral injury, characterized in that: The heat-nitrogen ratio of the enteral nutrition agent is in the range of 85-95:
1.
2. The use of the enteral nutrition agent according to claim 1 in preparing a preparation for improving the prognosis of patients with craniocerebral injury, characterized in that: The heat-nitrogen ratio of the enteral nutrition agent is in the range of 90-95:
1.
3. Use of the enteral nutrition agent according to claim 1 in preparing a preparation for improving the prognosis of patients with craniocerebral injury, characterized in that: The enteral nutrition agent is used for nutritional support of patients with severe craniocerebral injury, meeting the patient's daily energy intake of 2100-2300 Kcal, the patient's daily protein intake of 120-125 g / d, and non-protein calories of 1600-1800 kcal, calculated based on the patient's weight of 60 kg.
4. Use of the enteral nutrition agent according to claim 1 in preparing a preparation for improving the prognosis of patients with craniocerebral injury, characterized in that: Ensure that the total daily calorie intake ranges from 2100 to 2300 Kcal, the patient's daily carbohydrate intake is 200-250g, protein is 115-125g, fat is 70-78g, and the rest is vitamins and minerals.
5. Use of the enteral nutrition agent according to any one of claims 3 to 4 in preparing a preparation for improving the prognosis of patients with craniocerebral injury, characterized in that: Calculated by weight, the carbohydrates include 7-7.5 parts of monosaccharides, 75-80 parts of polysaccharides and lactose, and the lactose content is less than 0.185 parts.
6. Use of the enteral nutrition agent according to any one of claims 3 to 4 in preparing a preparation for improving the prognosis of patients with craniocerebral injury, characterized in that: The fat comprises 2-2.5 parts of saturated fatty acids and 8-8.5 parts of polyunsaturated fatty acids by mass.
7. Use of the enteral nutrition agent according to claim 4 in preparing a preparation for improving the prognosis of patients with craniocerebral injury, characterized in that: In parts by mass, the minerals include 0.5-0.7 parts of Na, 0.9-1 parts of K, 0.8-0.9 parts of CL, 0.4-0.5 parts of Ca, 0.4-0.5 parts of P, and 0.1-0.2 parts of Mg.
8. Use of the enteral nutrition agent according to claim 1 in preparing a preparation for improving the prognosis of patients with craniocerebral injury, characterized in that: Craniocerebral injury is a severe craniocerebral injury.
9. Use of an enteral nutrient in the preparation of a preparation for improving the prognosis of cerebral edema, characterized in that: The heat-nitrogen ratio of the enteral nutrition agent is in the range of 85-95:
1.
10. Use of an enteral nutrition agent in preparing a preparation for improving pulmonary edema, pleural effusion and prognosis, characterized in that: The heat-nitrogen ratio of the enteral nutrition agent is in the range of 85-95:1.
